Related references
Note: Only part of the references are listed.Impact of Obesity on Work Productivity in Different US Occupations: Analysis of the National Health and Wellness Survey 2014 to 2015
Ian Kudel et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2018)
Persistence of newer anti-obesity medications in a real-world setting
Rahul Ganguly et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Patrick M. O'Neil et al.
LANCET (2018)
The Impact of Obesity on Medical Care Costs and Labor Market Outcomes in the US
Adam Biener et al.
CLINICAL CHEMISTRY (2018)
Updated Review of Prevalence of Major Risk Factors and Use of Screening Tests for Cancer in the United States
Ann Goding et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2017)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013
Curtis S. Florence et al.
MEDICAL CARE (2016)
Low Adoption of Weight Loss Medications: A Comparison of Prescribing Patterns of Antiobesity Pharmacotherapies and SGLT2s
Catherine E. Thomas et al.
OBESITY (2016)
Cost-effectiveness thresholds in the USA: are they coming? Are they already here?
Robert W. Dubois
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2016)
Severe Obesity In Adults Cost State Medicaid Programs Nearly $8 Billion In 2013
Y. Claire Wang et al.
HEALTH AFFAIRS (2015)
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial
Melanie J. Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Paul E. Greenberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Xavier Pi-Sunyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010
Ying Xia et al.
OBESITY (2015)
The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA
Charles Baum et al.
PHARMACOECONOMICS (2015)
Antiobesity Pharmacotherapy: New Drugs and Emerging Targets
G. W. Kim et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Long-term Drug Treatment for Obesity A Systematic and Clinical Review
Susan Z. Yanovski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Cynthia L. Ogden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Economic costs of overweight and obesity
Thomas Lehnert et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Economic Costs of Diabetes in the U.S. in 2012
DIABETES CARE (2013)
Substantial Health And Economic Returns From Delayed Aging May Warrant A New Focus For Medical Research
Dana P. Goldman et al.
HEALTH AFFAIRS (2013)
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
T. A. Wadden et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
A Silent Response to the Obesity Epidemic Decline in US Physician Weight Counseling
Jennifer L. Kraschnewski et al.
MEDICAL CARE (2013)
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
Rena Wing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II)
Caroline M. Apovian et al.
OBESITY (2013)
Use of Prescription Antiobesity Drugs in the United States
Christian Hampp et al.
PHARMACOTHERAPY (2013)
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
W. Timothy Garvey et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Management of Obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008
Nithushi R. Samaranayake et al.
ANNALS OF EPIDEMIOLOGY (2012)
Anti-obesity drugs: past, present and future
R. John Rodgers et al.
DISEASE MODELS & MECHANISMS (2012)
The medical care costs of obesity: An instrumental variables approach
John Cawley et al.
JOURNAL OF HEALTH ECONOMICS (2012)
Anti-Obesity Drugs: A Review about Their Effects and Safety
Jun Goo Kang et al.
DIABETES & METABOLISM JOURNAL (2012)
Costs of asthma in the United States: 2002-2007
Sarah Beth L. Barnett et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Obesity 2 Health and economic burden of the projected obesity trends in the USA and the UK
Y. Claire Wang et al.
LANCET (2011)
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Kishore M. Gadde et al.
LANCET (2011)
The Financial Burden of Stress Urinary Incontinence Among Women in the United States
Erin C. Chong et al.
Current Urology Reports (2011)
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management.
Steven R. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Economic impact of epilepsy in the United States
Dokyoung Yoon et al.
EPILEPSIA (2009)
Comparing Adherence and Persistence Across 6 Chronic Medication Classes
Jason Yeaw et al.
JOURNAL OF MANAGED CARE PHARMACY (2009)
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
G. A. Bray et al.
LANCET (2009)
Long term pharmacotherapy for obesity and overweight: updated meta-analysis
Diana Rucker et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Occupation-specific absenteeism costs associated with obesity and morbid obesity
John Cawley et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2007)
Drug treatments for obesity: orlistat, sibutramine, and rimonabant
Raj S. Padwal et al.
LANCET (2007)
The economic burden of major adult visual disorders in the United States
David B. Rein et al.
ARCHIVES OF OPHTHALMOLOGY (2006)
Lost productive time associated with excess weight in the US workforce
JA Ricci et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2005)
Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span
R Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The impact of obesity on health-related quality-of-life in the general adult US population
HM Jia et al.
JOURNAL OF PUBLIC HEALTH (2005)
Efficacy of lifestyle modification for long-term weight control
TA Wadden et al.
OBESITY RESEARCH (2004)
The value of a statistical life: A critical review of market estimates throughout the world
WK Viscusi et al.
JOURNAL OF RISK AND UNCERTAINTY (2003)
Share Paper
